US Drug Eluting Sinus Stent (DESS) Industrial and Market studies: Size, Trends & Forecasts (2016-2021)

"US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

Scope of the Report

The report entitled US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021), provides analysis of the US DESS market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value (TAM), by volume and by utilization. The report also provides the analysis of the US sinus surgery market, including analysis of FESS market and BSD market.

Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=810264

Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US DESS market has also been forecasted for the years 2016-2021, taking into consideration the growth pattern of sinus surgery market, the growth drivers and the current and future trends.

Intersect is the only company manufacturing drug eluting sinus stents, but the competitive landscape of the market includes other indirect competitors, such as Medtronic, Entellus Medical and Acclarent (J&J), whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Company Coverage

Intersect ENT

Medtronic (Xomed)

Entellus Medical

Acclarent (J&J)

To Enquire Regarding This Report @ http://www.researchmoz.us/enquiry.php?type=E&repid=810264

Executive Summary

Sinuses are the hollow cavities located in the bones of the face and around the nose. There are four sinus cavities: frontal, maxillary, ethmoid, and sphenoid, each with different features. Under normal conditions, the secretion (mucous) flow through the nasal passages, but with the onset of sinusitis, the secretion gets blocked in the sinuses due to inflammation. Sinusitis disturbs the normal lifestyle of a person and sometimes become frustrating, as it affects the persons breathing, sleeping and eating.

Sinusitis can be divided into Acute Sinusitis, Recurrent Acute Rhinosinusitis (RARS) and chronic Rhinosinusitis (CRS), on the basis of the duration of the episode of sinusitis and its severity. The treatment options for the sinusitis can be over-the-counter treatment, medical management and surgery. The OTC treatment includes decongestants, antihistamines, pain relievers and nasal irrigation. Medical management includes antibiotics and oral and nasal steroids. The sinus surgeries are mainly of two types: Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD).

Intersect, is the only company that has developed drug releasing bio-absorbable implants (drug eluting sinus stents- DESS) that enable targeted and sustained release of therapeutic agents, increasing the effectiveness of the sinus surgery.

For More Information Kindly Contact:

ResearchMoz Global Pvt. Ltd.

90 State Street,
Albany, NY 12207,
United Stateshttp://www.researchmoz.us,Blog - http://bit.ly/2b1Ayn6 866-997-4948 (Us-Canada Toll Free),
+1-518-621-2074,Email to: sales@researchmoz.us,